Evidence map›Paper›PMID 22042266›Full record

ReviewEnvironmental health perspectives2012

Do interactions between gut ecology and environmental chemicals contribute to obesity and diabetes?

Suzanne M Snedeker, Anthony G Hay

Open access · diamondAbstract readReview
In one paragraph

Review in Environmental health perspectives, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 183 citations in OpenAlex.

  1. Endocrine disruptors, obesity, and metabolic syndrome.Turkish journal of medical sciences · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Mechanisms of Immunotoxicity: Stressors and Evaluators.International journal of molecular sciences · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Agrochemicals and obesity.Molecular and cellular endocrinology · 2020
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Role of Obesogens in the Pathogenesis of Obesity.Medicina (Kaunas, Lithuania) · 2019
    Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Suzanne M SnedekerDepartment of Microbiology and the Institute for Comparative and Environmental Toxicology, Cornell University, Ithaca, New York 14853, USA.
Anthony G Hay
Cornell University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGut microbiota are important factors in obesity and diabetes, yet little is known about their role in the toxicodynamics of environmental chemicals, including those recently found to be obesogenic and diabetogenic.

objectivesWe integrated evidence that independently links gut ecology and environmental chemicals to obesity and diabetes, providing a framework for suggesting how these environmental factors may interact with these diseases, and identified future research needs.

methodsWe examined studies with germ-free or antibiotic-treated laboratory animals, and human studies that evaluated how dietary influences and microbial changes affected obesity and diabetes. Strengths and weaknesses of studies evaluating how environmental chemical exposures may affect obesity and diabetes were summarized, and research gaps on how gut ecology may affect the disposition of environmental chemicals were identified.

resultsMounting evidence indicates that gut microbiota composition affects obesity and diabetes, as does exposure to environmental chemicals. The toxicology and pharmacology literature also suggests that interindividual variations in gut microbiota may affect chemical metabolism via direct activation of chemicals, depletion of metabolites needed for biotransformation, alteration of host biotransformation enzyme activities, changes in enterohepatic circulation, altered bioavailability of environmental chemicals and/or antioxidants from food, and alterations in gut motility and barrier function.

conclusionsVariations in gut microbiota are likely to affect human toxicodynamics and increase individual exposure to obesogenic and diabetogenic chemicals. Combating the global obesity and diabetes epidemics requires a multifaceted approach that should include greater emphasis on understanding and controlling the impact of interindividual gut microbe variability on the disposition of environmental chemicals in humans.

Indexed as

AnimalsDiabetes MellitusEnvironmental PollutantsFemaleGastrointestinal TractHumansMaleMiceObesityRatsXenobioticsEnvironmental PollutantsXenobiotics

Identifiers

PMID22042266
PMCPMC3295356
OpenAlexW2001710713

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.